Hillenbrand sells majority stake in Milacron

On 5 February, the US company Hillebrad entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection moulding and extrusion business to an affiliate of Bain Capital for 287 million dollars. The Company will retain an ownership stake of approximately 49%.

This transaction reflects the continued execution of Hillenbrand's portfolio transformation and profitable growth strategy. The net proceeds after tax are expected to be approximately 250 million dollars and will be used for debt paydown. In fiscal year 2024, Milacron generated 526 million dollars in revenue and 64 million dollars in adjusted Ebitda.

"The agreement to divest a majority stake in the Milacron business reflects the continuation of Hillenbrand's transformation as we've significantly reshaped our portfolio toward less cyclical, higher-growth opportunities. We believe this transaction not only delivers value for Hillenbrand and our shareholders, but also Milacron and its customers, as they have a strong partner in Bain Capital to help drive their next phase of growth", said Kim Ryan, President and Chief Executive Officer of Hillenbrand.